![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | ![]() XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
| ![]() Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. | |
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2005 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Houston, US HQ | Locations Austin, US HQ | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US |
Employees | Employees 64 | Employees 4426% increase | Employees 8510% decrease | Employees 1241% increase |
Valuation ($) | Valuation ($) 69.8 m | Valuation ($) 1.8 m | Valuation ($) 234.4 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($129.9m) (FY, 2024) | Net income ($26.9m) (FY, 2024) | Net income ($45.5m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 176m | Total funding raised $ 135k | Total funding raised N/A | Total funding raised $ 451.9m |
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
View company
Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.
View company